Literature DB >> 1841683

Structural studies of gangliosides from the YAC-1 mouse lymphoma cell line by immunological detection and fast atom bombardment mass spectrometry.

J Müthing1, J Peter-Katalinić, F G Hanisch, U Neumann.   

Abstract

YAC-1 cells were propagated in bioreactors in 1 l and 7.5 l volumes. The cells were metabolically labelled with D-[1-14C]galactose and D-[1-14C]glucosamine. The ganglioside fraction, purified by DEAE-Sepharose and silica gel column chromatography, showed on thin layer chromatography four major bands with mobilities between GM1 and GD1a. Gangliosides, obtained by further purification steps including high performance liquid chromatography on silica gel 60 columns with a gradient system of isopropanol:hexane:water, and preparative high performance TLC were characterized by (1) immunostaining of corresponding asialogangliosides obtained by mild acid hydrolysis and neuraminidase treatment and (2) fast atom bombardment mass spectrometry of native and permethylated samples and methylation analysis of GM1b ganglioside. As well as small amounts of GM2 and GM1, the major gangliosides found in the complex mixture were GM1b and GalNAc-GM1b. The structural heterogeneity of these gangliosides was caused by (a) substitution of the ceramide moiety by fatty acids of different chain length and degree of unsaturation (C16:0, C24:0, C24:1) and (b) N-substitution of the sialic acid moieties with either acetyl or glycolyl groups. Disialogangliosides were detected only in low amounts and will be the subject of further investigation. A polyclonal chicken antiserum was raised against IVNeuAc-GgOse5Cer. The antiserum was highly specific for gangliosides (IVNeuAc and IVNeuGc) and asialogangliosides with a GgOse5Cer backbone. No cross-reaction with GM1b or GgOse4Cer was observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1841683     DOI: 10.1007/bf00731293

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  36 in total

1.  Structure of a new disialoganglioside GD1c from spontaneous murine thymoma.

Authors:  Z Bartoszewicz; J Kościelak; T Pacuszka
Journal:  Carbohydr Res       Date:  1986-08-15       Impact factor: 2.104

2.  Biosynthesis of gangliosides from asialogangliosides in rat liver Golgi vesicles.

Authors:  G Pohlentz; D Klein; D Schmitz; G Schwarzmann; J Peter-Katalinić; K Sandhoff
Journal:  Biol Chem Hoppe Seyler       Date:  1988-01

3.  Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain.

Authors:  L Svennerholm; J E Månsson; Y T Li
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

4.  Sensitive enzyme-immunostaining and densitometric determination of ganglio-series gangliosides on thin-layer plate: pmol detection of gangliosides in cerebrospinal fluid.

Authors:  Y Hirabayashi; K Koketsu; H Higashi; Y Suzuki; M Matsumoto; M Sugimoto; T Ogawa
Journal:  Biochim Biophys Acta       Date:  1986-03-21

5.  Detection of gangliosides of the GM1b type on high-performance thin-layer chromatography plates by immunostaining after neuraminidase treatment.

Authors:  J Müthing; P F Mühlradt
Journal:  Anal Biochem       Date:  1988-08-15       Impact factor: 3.365

6.  A new ganglioside showing choleragenoid-binding activity in mouse spleen.

Authors:  K Nakamura; M Suzuki; F Inagaki; T Yamakawa; A Suzuki
Journal:  J Biochem       Date:  1987-04       Impact factor: 3.387

7.  Glycolipids of murine lymphocyte subpopulations. Structural characterization of thymus gangliosides.

Authors:  G A Schwarting; A Gajewski
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

8.  Forssman glycolipid, an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes.

Authors:  U Bethke; B Kniep; P F Mühlradt
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  High resolution preparative column chromatographic system for gangliosides using DEAE-Sephadex and a new porus silica, Iatrobeads.

Authors:  T Momoi; S Ando; Y Magai
Journal:  Biochim Biophys Acta       Date:  1976-09-27

Review 10.  Tumor-associated glycolipid antigens, their metabolism and organization.

Authors:  S Hakomori
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

View more
  7 in total

1.  Ganglioside expression in tissues of mice lacking beta2-microglobulin.

Authors:  A Markotić; A Marusić; J Tomac; J Müthing
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Neutral glycosphingolipids and gangliosides from spleen T lymphoblasts of genetically different inbred mouse strains.

Authors:  J Müthing
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.

Authors:  J Müthing; M Cacić
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

4.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

5.  Different binding capacities of influenza A and Sendai viruses to gangliosides from human granulocytes.

Authors:  J Müthing; F Unland; D Heitmann; M Orlich; F G Hanisch; J Peter-Katalinić; V Knäuper; H Tschesche; S Kelm; R Schauer
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

6.  Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro.

Authors:  H Brandt; J Müthing; J Peter-Katalinić; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

7.  Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium.

Authors:  J Müthing; A Pörtner; V Jäger
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.